Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl R Clauser

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Cell|April 15, 2025
Precision proteogenomics reveals pan-cancer impact of germline variantsFernanda Martins Rodrigues, Nadezhda V Terekhanova, Kathleen J Imbach, et al.
Cell|June 25, 2021
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFsShira Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, et al.
Nature Communications|April 26, 2017
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
Nature Communications|March 29, 2017
Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
Cell|November 19, 2020
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted TherapyKarsten Krug, Eric J Jaehnig, Shankha Satpathy, et al.
Cell|March 1, 2025
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapyQinqin Jiang, David A Braun, Karl R Clauser, et al.
Cell|August 15, 2023
Pan-cancer proteogenomics connects oncogenic drivers to functional statesYize Li, Eduard Porta-Pardo, Collin Tokheim, et al.
The Journal of Clinical Investigation|July 1, 2022
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinomaPatrick C Lee, Susan Klaeger, Phuong M Le, et al.
Cell|July 11, 2020
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung AdenocarcinomaMichael A Gillette, Shankha Satpathy, Song Cao, et al.
Cell|August 6, 2021
A proteogenomic portrait of lung squamous cell carcinomaShankha Satpathy, Karsten Krug, Pierre M Jean Beltran, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Cell|April 15, 2025
Precision proteogenomics reveals pan-cancer impact of germline variantsFernanda Martins Rodrigues, Nadezhda V Terekhanova, Kathleen J Imbach, et al.
Cell|June 25, 2021
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFsShira Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, et al.
Nature Communications|April 26, 2017
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
Nature Communications|March 29, 2017
Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
Cell|November 19, 2020
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted TherapyKarsten Krug, Eric J Jaehnig, Shankha Satpathy, et al.
Cell|March 1, 2025
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapyQinqin Jiang, David A Braun, Karl R Clauser, et al.
Cell|August 15, 2023
Pan-cancer proteogenomics connects oncogenic drivers to functional statesYize Li, Eduard Porta-Pardo, Collin Tokheim, et al.
The Journal of Clinical Investigation|July 1, 2022
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinomaPatrick C Lee, Susan Klaeger, Phuong M Le, et al.
Cell|July 11, 2020
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung AdenocarcinomaMichael A Gillette, Shankha Satpathy, Song Cao, et al.
Cell|August 6, 2021
A proteogenomic portrait of lung squamous cell carcinomaShankha Satpathy, Karsten Krug, Pierre M Jean Beltran, et al.
Pageof 10